Gastritis

Last updated

Gastritis
Gastritis helicobacter - intermed mag.jpg
Micrograph showing gastritis. H&E stain.
Specialty Gastroenterology
Symptoms Upper abdominal pain, nausea, vomiting, bloating, indigestion, loss of appetite, heartburn [1] [2]
Complications Bleeding, stomach ulcers, stomach tumors, pernicious anemia [1] [3]
DurationShort or long term [1]
Causes Helicobacter pylori or other pathogens, NSAIDs, alcohol, cocaine, acute stress or physiological shock, autoimmune response [1]
Diagnostic method Endoscopy with biopsy, upper gastrointestinal series, blood tests, stool tests [1]
Differential diagnosis Myocardial infarction, inflammation of the pancreas, gallbladder problems, peptic ulcer disease [2]
Treatment Antacids, H2 blockers, proton pump inhibitors, antibiotics, sucralfate, bismuth subsalicylate, [1] antiemetics
Frequency30% - 50% of people [4]
Deaths50,000 (2015) [5]

Gastritis is the inflammation of the lining of the stomach. [1] It may occur as a short episode or have a long duration. [1] There may be no symptoms, but the most common symptom is upper abdominal pain. [1] Other symptoms include nausea and vomiting, bloating, indigestion, loss of appetite and heartburn. [1] [2] Complications may include stomach bleeding, stomach ulcers, and stomach tumors. [1] Autoimmune atrophic gastritis may lead to issues including pernicious anemia. [3]

Contents

Common causes include infection with Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs (NSAIDs). [1] Other causes include alcohol, smoking, cocaine, severe illness, autoimmune problems, radiation therapy and Crohn's disease. [1] [6] Endoscopy, a type of X-ray known as an upper gastrointestinal series, blood tests, and stool tests may help with diagnosis. [1] Other conditions with similar symptoms include inflammation of the pancreas, gallbladder problems, and peptic ulcer disease. [2]

Prevention involves avoidance of things which irritate the gut and which trigger symptoms, including alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), tobacco, and certain foods. [4] [ examples needed ] It is also recommended to treat for any underlying H. pylori infection before starting NSAID treatment in order to prevent irritation and gastroduodenal ulcers. [7] Treatment includes medications such as antacids, H2 blockers, and proton pump inhibitors. [1] During an acute flare-up, drinking viscous lidocaine may help. [8] If gastritis is caused by NSAID use (e.g. aspirin, ibuprofen, naproxen), usage may be ceased. [1] If H. pylori is present, it may be treated with a combination of antibiotics such as amoxicillin and clarithromycin. [1] For those with pernicious anemia, vitamin B12 supplements are recommended by injection. [3]

Gastritis is believed to be present in 30% to 50% of people worldwide, but most cases are asymptomatic. [4] In 2013 there were approximately 90 million new cases of the condition. [9] The risk of developing gastritis increases as one ages. [4] Gastritis, along with a similar condition in the first part of the intestines called duodenitis, resulted in 50,000 deaths in 2015. [5] H. pylori was first discovered in 1981 by Barry Marshall and Robin Warren. [10]

Classification

Updated Sydney System (USS) for classification of gastritis based on morphological features. Updated Sydney System for visual classification of gastritis.png
Updated Sydney System (USS) for classification of gastritis based on morphological features.

There are multiple classification systems which may be used to categorise gastritis cases. The Updated Sydney System (USS) of 1994 is commonly used for classification, based primarily on the morphological features of the disease seen in endoscopic biopsies. The Kyoto system (from the 2015 Kyoto Consensus Conference) classifies gastritis based primarily on the cause and duration of symptoms, resulting in the 3 types acute, chronic, and special. [11] Gastritis may also be classified based on the kind of mucosal injury, resulting in the 2 types erosive and non-erosive. [12] [13]

The Operative Link for Gastritis Assessment (OLGA) staging system may also be used to classify cases of gastritis. [14] The OLGA system was devised in an attempt to evaluate complication risk, in particular the development of gastritis into intestinal metaplasia or gastric cancer. The degree of atrophy and metaplasia at two main sites is scored on a four-tiered scale. [15]

Corpus
No atrophy
(score 0)		Mild atrophy
(score 1)		Moderate atrophy
(score 2)		Severe atrophy
(score 3)
Antrum
(including
incisura
angularis)
No atrophy (score 0)Stage 0Stage IStage IIStage II
Mild atrophy (score 1)Stage IStage IStage IIStage III
Moderate atrophy (score 2)Stage IIStage IIStage IIIStage IV
Severe atrophy (score 3)Stage IIIStage IIIStage IVStage IV

Signs and symptoms

A peptic ulcer, which may accompany gastritis, seen via endoscopy. Deep gastric ulcer.png
A peptic ulcer, which may accompany gastritis, seen via endoscopy.

Many people with gastritis experience no symptoms at all. However, upper central abdominal pain is the most common symptom; the pain may be dull, vague, burning, aching, gnawing, sore, or sharp. [16] Pain is usually located in the upper central portion of the abdomen, but it may occur anywhere from the upper left portion of the abdomen around to the back. [17]

Other signs and symptoms may include the following: [16]

Causes

Infection

Helicobacter pylori infection is the most common cause of gastritis; when contracted this way, it may be termed H. pylori gastritis. [18] [19] H. pylori is a kind of bacteria which colonizes the gut of more than half of the world's population. While the bacteria is present in over half of the world's population, infection does not necessarily cause symptoms and thus most cases are asymptomatic. [20] It has been suggested that H. pylori plays an important role in the natural stomach ecology. [21]

While H. pylori is the most common infectious cause of gastritis, there are other pathogens which can cause the disease. Uncommon causes include those of the genera Cytomegalovirus and Candida. Rare bacterial causes include Helicobacter heilmannii, Escherichia coli, and those of the genera Actinomyces, Clostridium, Mycobacterium, Proteus, Spirochaete, Streptococcus, and Staphylococcus. Rare fungal causes include those of the genus Histoplasma and those which can cause Phycomycosis. Rare parasitic causes include Ascaris lumbricoides and those of the parasitic genera Anisakis, Strongyloides, and Cryptosporidium. [7] [18]

Drugs

Gastritis can result from usage of some drugs, the most common being usage of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, and naproxen. Other drugs include cocaine, iron, colchicine when administered at toxic levels, kayexalate (a kind of polystyrene sulfonate), ticlopidine, and those associated with chemotherapy and immunotherapy for cancer. [7] [18] Drugs used for COVID-19 treatment have also been found to cause gastritis; tocilizumab and sarilumab are associated with chronic gastritis, while lopinavir/ritonavir is associated with the acute form. [7]

Stress, injury, and illness

Gastritis (usually acute gastritis) may develop after acute stress, shock, and direct trauma. [7] [18] Specific conditions include uremia, ischemia (specifically in the stomach), sepsis, and food poisoning. [4] [7] [11] Gastritis may also develop after major surgery or traumatic injury (Cushing ulcer), burns (Curling ulcer), or severe infections.[ citation needed ] Gastritis may also occur in those who have had weight loss surgery resulting in the banding or reconstruction of the digestive tract.[ citation needed ]

Gastritis is also associated with bile reflux, in which bile and/or pancreatic enzymes flow up into the stomach; when bile travels further upwards into the esophagus, it is called gastric reflux. Excessive refluxed bile in the stomach causes irritation and inflammation to the stomach lining, leading to the development of gastric ulcers and/or gastritis; when contracted this way, it may be termed bile reflux gastritis. [22] [23]

Autoimmune (atrophic)

Autoimmune atrophic gastritis is a chronic form of gastritis caused by the destruction of gastric parietal cells due to an autoimmune response. [24] These cells in the stomach produce intrinsic factor necessary for the absorption of vitamin B12, and their destruction can result in vitamin B12 deficiency. Later stages of autoimmune atrophic gastritis may develop into pernicious anemia or megaloblastic anemia. [25] [26]

Diet

Evidence does not support a role for specific foods, including spicy foods and coffee, in the development of peptic ulcers. [27] People are, however, usually advised to avoid foods that trigger symptoms. [28] There is little specific advice on diet published by authoritative sources. The National Health Service of the United Kingdom advises avoiding spicy, acidic or fried foods which may irritate the stomach. [29]

It is generally advised to avoid alcohol consumption for the prevention and mitigation of gastrointestinal injury. [4] [7] Some sources describe alcohol as a potential cause of gastritis, [1] [4] [13] while others describe it instead as a potential contributor to the erosion of the stomach's mucosal lining when ingested in large doses. [30] [31]

Diagnosis

Gastritis should be investigated when a patient reports abdominal discomfort, pain, and/or nausea. [13] Diagnosis relies primarily on the findings of an upper endoscopy with biopsy, but also involves taking a comprehensive patient history. [4] [11] While history and other tests can help provide insights, histopathological examination of gastric biopsies are the gold standard, and allow one to identify the distribution, severity, and etiology of the disease. [11]

Other tests which may be ordered to diagnose or rule out gastritis include:

Treatment

Antacids are a common treatment for mild to medium gastritis. [32] When antacids do not provide enough relief, medications such as H2 blockers and proton-pump inhibitors that help reduce the amount of acid are often prescribed. [32] [33]

Cytoprotective agents are designed to help protect the tissues that line the stomach and small intestine. [34] They include the medications sucralfate and misoprostol. If NSAIDs are being taken regularly, one of these medications to protect the stomach may also be taken. Another cytoprotective agent is bismuth subsalicylate. [35]

Several regimens are used to treat H. pylori infection. Most use a combination of two antibiotics and a proton pump inhibitor. Sometimes bismuth is added to the regimen.[ citation needed ]

History

Gastric cancer was first described in 1000 A.D. by Persian physician Avicenna. In 1728, German physician Georg Ernst Stahl coined the term "gastritis". Italian anatomical pathologist Giovanni Battista Morgagni further described the characteristics of gastric inflammation, including the characteristics of erosive or ulcerative gastritis and erosive gastritis. Between 1808 and 1831, French physician François-Joseph-Victor Broussais gathered information from autopsies of dead French soldiers. He described chronic gastritis as "gastritide" and erroneously believed that gastritis was the cause of ascites, typhoid fever, and meningitis. In 1854, Charles Handfield Jones and Wilson Fox described the microscopic changes of the stomach's inner lining in gastritis. In 1855, Baron Carl von Rokitansky first described hypertrophic gastritis. In 1859, British physician William Brinton first described acute, subacute, and chronic gastritis. In 1870, Samuel Fenwick noted that pernicious anemia causes glandular atrophy in gastritis. German surgeon Georg Ernst Konjetzny noticed that both gastric ulcers and gastric cancer are the results of gastric inflammation. Shields Warren and Willam A. Meissner described the intestinal metaplasia of the stomach as a feature of chronic gastritis. [36]

Pathophysiology

Acute

Early acute superficial gastritis. Marked neutrophilic infiltrates appear in the mucous neck region and lamina with a pit microabscess. This case was caused by Helicobacter pylori. Histopathology of early acute superficial gastritis.png
Early acute superficial gastritis. Marked neutrophilic infiltrates appear in the mucous neck region and lamina with a pit microabscess. This case was caused by Helicobacter pylori .

Acute erosive gastritis typically involves discrete foci of surface necrosis due to damage to mucosal defenses. [37] NSAIDs inhibit cyclooxygenase-1, or COX-1, an enzyme responsible for the biosynthesis of eicosanoids in the stomach, increasing the likelihood of peptic ulcers forming. [38] [39] [40] NSAIDs also inhibit prostaglandin synthesis, a hormone with a protective effect on the stomach's mucosal lining. While short-term NSAID use causes no problems, long-term use can lead to gastritis or other complications. [41] [30]

Metaplasia

Metaplasia is the transformation of differentiated cells from one type into another type. Mucous gland metaplasia can occur after severe damage to the gastric glands causes them to waste away (atrophic gastritis) and be progressively replaced by mucous glands. Gastric ulcers may develop; it is unclear if they are the causes or the consequences. [37]

Intestinal metaplasia typically begins in response to chronic mucosal injury in the antrum and may extend to the body. Gastric mucosa cells change to resemble intestinal mucosa and may even assume absorptive characteristics. Intestinal metaplasia is classified histologically as complete or incomplete. In the complete type, gastric mucosa is completely transformed into small-bowel mucosa, both histologically and functionally, with the ability to absorb nutrients and secrete peptides. In the incomplete type, the epithelium assumes a histologic appearance closer to that of the large intestine and frequently exhibits dysplasia. [37]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 "Gastritis". The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). November 27, 2013. Archived from the original on 6 March 2015. Retrieved 1 March 2015.
  2. 1 2 3 4 5 Rosen & Barkin's 5-Minute Emergency Medicine Consult (4 ed.). Lippincott Williams & Wilkins. 2012. p. 442. ISBN   978-1-4511-6097-0. Archived from the original on 2015-04-02.
  3. 1 2 3 Varbanova M, Frauenschläger K, Malfertheiner P (Dec 2014). "Chronic gastritis - an update". Best Pract Res Clin Gastroenterol. 28 (6): 1031–42. doi:10.1016/j.bpg.2014.10.005. PMID   25439069.
  4. 1 2 3 4 5 6 7 8 9 10 11 Fred F. Ferri (2012). Ferri's Clinical Advisor 2013,5 Books in 1, Expert Consult - Online and Print,1: Ferri's Clinical Advisor 2013. Elsevier Health Sciences. p. 417. ISBN   978-0-323-08373-7. Archived from the original on 2016-03-05.
  5. 1 2 Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". The Lancet . 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. eISSN   1474-547X. ISSN   0140-6736. PMC   5388903 . PMID   27733281. (GBD 2015 Mortality and Causes of Death Collaborators).
  6. ↑ Hauser, Stephen (2014). Mayo Clinic Gastroenterology and Hepatology Board Review. Oxford University Press. p. 49. ISBN   978-0-19-937333-8. Archived from the original on 2016-03-05.
  7. 1 2 3 4 5 6 7 8 9 10 El-Nakeep S (3 February 2023). "Acute Gastritis Treatment & Management". Medscape. Retrieved 27 November 2025.
  8. ↑ Adams (2012). "32". Emergency Medicine: Clinical Essentials. Elsevier Health Sciences. ISBN   978-1-4557-3394-1. Archived from the original on 2016-08-15.
  9. ↑ Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (22 August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". The Lancet . 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. eISSN   1474-547X. ISSN   0140-6736. PMC   4561509 . PMID   26063472. (Global Burden of Disease Study 2013 Collaborators).
  10. ↑ Wang AY, Peura DA (October 2011). "The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world". Gastrointestinal Endoscopy Clinics of North America. 21 (4): 613–635. doi:10.1016/j.giec.2011.07.011. ISSN   1558-1950. PMID   21944414.
  11. 1 2 3 4 Azer SA, Awosika AO, Akhondi H (2024-06-22), "Gastritis", StatPearls, StatPearls Publishing, PMID   31334970 , retrieved 2025-11-27
  12. ↑ Medcrine. "Gastritis: Causes, Classification, Diagnosis and Treatment". Medcrine. Retrieved 2025-11-27.
  13. 1 2 3 Vakil N (June 2021). "Gastritis - Digestive Disorders". MSD Manual Consumer Version . Merck & Co. Archived from the original on 13 August 2021. Retrieved 25 February 2022.
  14. ↑ Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. (May 2007). "Gastritis staging in clinical practice: the OLGA staging system". Gut. 56 (5): 631–636. doi:10.1136/gut.2006.106666. ISSN   0017-5749. PMC   1942143 . PMID   17142647.
  15. ↑ Carrasco G, Corvalan AH (2013). "Helicobacter pylori-Induced Chronic Gastritis and Assessing Risks for Gastric Cancer". Gastroenterol Res Pract. 2013 393015. doi: 10.1155/2013/393015 . PMC   3745848 . PMID   23983680. Creative Commons by small.svg  This article incorporates text available under the CC BY 3.0 license.
  16. 1 2 "Gastritis Symptoms". eMedicineHealth. 2008. Archived from the original on 2008-12-06. Retrieved 2008-11-18.
  17. ↑ "Gastritis". National Digestive Diseases Information Clearinghouse. National Institute of Diabetes and Digestive and Kidney Diseases. December 2004. Archived from the original on 2008-10-11. Retrieved 2008-10-06.
  18. 1 2 3 4 Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al. (2011-03-01). "Gastritis: The histology report". Digestive and Liver Disease. 43: S373 –S384. doi:10.1016/S1590-8658(11)60593-8. ISSN   1590-8658. PMID   21459343.
  19. ↑ Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. (2022-08-08). "Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report". Gut. 71 (9): 1724–1762. doi:10.1136/gutjnl-2022-327745. hdl: 10807/227059 . ISSN   0017-5749. PMID   35944925. Archived from the original on 2025-06-06.
  20. ↑ "Helicobacter pylori (H. pylori) and Cancer - NCI". www.cancer.gov. 2013-09-25. Retrieved 2025-11-27.
  21. ↑ Blaser MJ (2006). "Who are we? Indigenous microbes and the ecology of human diseases" (PDF). EMBO Reports. 7 (10): 956–60. doi:10.1038/sj.embor.7400812. PMC   1618379 . PMID   17016449. Archived (PDF) from the original on 2012-11-05.
  22. ↑ Shi X, Chen Z, Yang Y, Yan S (2022). "Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management". Gastroenterology Research and Practice. 2022 (1) 2642551. doi: 10.1155/2022/2642551 . ISSN   1687-630X. PMC   9484982 . PMID   36134174.
  23. ↑ McCabe ME, Dilly CK (2018-09-01). "New Causes for the Old Problem of Bile Reflux Gastritis". Clinical Gastroenterology and Hepatology. 16 (9): 1389–1392. doi:10.1016/j.cgh.2018.02.034. ISSN   1542-3565. PMID   29505908.
  24. ↑ Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, et al. (2020-07-09). "Autoimmune gastritis" . Nature Reviews Disease Primers. 6 (1): 56. doi:10.1038/s41572-020-0187-8. ISSN   2056-676X. PMID   32647173.
  25. ↑ Kulnigg-Dabsch S (October 2016). "Autoimmune gastritis". Wiener Medizinische Wochenschrift (1946). 166 (13–14): 424–430. doi:10.1007/s10354-016-0515-5. ISSN   1563-258X. PMC   5065578 . PMID   27671008.
  26. ↑ Esposito G, Dottori L, Pivetta G, Ligato I, Dilaghi E, Lahner E (2022-04-17). "Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency". Nutrients. 14 (8): 1672. doi: 10.3390/nu14081672 . ISSN   2072-6643. PMC   9030741 . PMID   35458234.
  27. ↑ Raphael Rubin, David S. Strayer, Emanuel Rubin, eds. (2012). Rubin's pathology: clinicopathologic foundations of medicine (Sixth ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 623. ISBN   978-1-60547-968-2. Archived from the original on 2015-04-02.
  28. ↑ Webster-Gandy, Joan, Madden, Angela, Holdsworth, Michelle, eds. (2012). Oxford handbook of nutrition and dietetics (2nd ed.). Oxford: Oxford University Press, USA. p. 571. ISBN   978-0-19-958582-3. Archived from the original on 2017-09-08.
  29. ↑ "Gastritis: Things you can do to ease gastritis". National Health Service . 2019-05-20. Retrieved 2021-08-29.
  30. 1 2 Siegelbaum J (23 August 2019). "GI Health Resources > Gastritis". Jackson Siegelbaum Gastroenterology. Archived from the original on 15 June 2021. Retrieved 25 February 2022.
  31. ↑ Wolff G (1970-04-30). "Does Alcohol Cause Chronic Gastritis?". Scandinavian Journal of Gastroenterology. 5 (4): 289–291. doi:10.1080/00365521.1970.12096591. ISSN   0036-5521. PMID   5429892.
  32. 1 2 Zajac P, Holbrook A, Super ME, Vogt M (March–April 2013). "An overview: Current clinical guidelines for the evaluation, diagnosis, treatment, and management of dyspepsia". Osteopathic Family Physician. 5 (2): 79–85. doi:10.1016/j.osfp.2012.10.005.
  33. ↑ Boparai V, Rajagopalan J, Triadafilopoulos G (2008). "Guide to the use of proton pump inhibitors in adult patients". Drugs. 68 (7): 925–47. doi:10.2165/00003495-200868070-00004. PMID   18457460. S2CID   29732662.
  34. ↑ Fashner J, Gitu AC (15 February 2015). "Diagnosis and Treatment of Peptic Ulcer Disease and H. pylori Infection". American Family Physician. 91 (4): 236–42. PMID   25955624.
  35. ↑ "Gastritis". The Lecturio Medical Concept Library. Retrieved 22 July 2021.
  36. ↑ Gyula M (16 January 2013). "Chapter 1: Diagnosis of Gastritis – Review from Early Pathological Evaluation to Present Day Management" (PDF). Current Topics in gastritis. University of Pécs. pp. 1–19. ISBN   978-953-51-0907-5 . Retrieved 10 July 2018.
  37. 1 2 3 Vakil N (January 2007). "Gastritis". Merck Manual - Professional Version . Merck & Co. Archived from the original on 25 January 2009. Retrieved 11 January 2009.
  38. ↑ Dajani EZ, Islam K (1 August 2008). "Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man" (PDF). Journal of Physiology and Pharmacology. 59 (Suppl 2): 117–133. ISSN   1899-1505. OCLC   165902827. PMID   18812633.[ permanent dead link ]
  39. ↑ Yokoyama C, Tanabe T (15 December 1989). "Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme". Biochemical and Biophysical Research Communications . 165 (2): 888–94. Bibcode:1989BBRC..165..888Y. doi:10.1016/S0006-291X(89)80049-X. eISSN   1090-2104. ISSN   0006-291X. LCCN   61065129. OCLC   1532958. PMID   2512924.
  40. ↑ Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA (1 June 1991). "Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment". The FASEB Journal . 5 (9): 2304–2312. doi: 10.1096/fasebj.5.9.1907252 . eISSN   1530-6860. ISSN   0892-6638. LCCN   87644294. OCLC   1096896944. PMID   1907252. S2CID   46147389.
  41. ↑ Wallace JL (October 2008). "Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?" . Physiological Reviews. 88 (4): 1547–1565. doi:10.1152/physrev.00004.2008. ISSN   0031-9333. PMID   18923189.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.